Integra LifeSciences to Present at the 36th Annual J.P. Morgan Healthcare Conference
December 21 2017 - 04:15PM
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading
global medical technology company, today announced President and
Chief Executive Officer Peter Arduini will speak at the 36th Annual
J.P. Morgan Healthcare Conference in San Francisco, California at
3:30 p.m. PT (6:30 p.m. ET) on Wednesday, January 10, 2018.
A live audio webcast of the presentation will be
available on the Investors section of the company’s website at
www.integralife.com.
About Integra LifeSciencesIntegra LifeSciences
(NASDAQ:IART) is dedicated to limiting uncertainty for clinicians,
so they can concentrate on providing the best patient care.
Integra offers innovative solutions, including leading
plastic and regenerative technologies, in specialty surgical
solutions and orthopedics and tissue technologies. For more
information, please visit www.integralife.com.
Statements made at the upcoming conferences may
be forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties that could cause actual
results to differ from predicted results. Forward-looking factors
that may be discussed include, but are not limited to, future
financial performance, new product development, governmental
approvals, market potential and resulting sales as well as
potential therapeutic applications, and additional acquisitions.
These risks and uncertainties include market conditions and other
factors beyond the Company's control and the economic, competitive,
governmental, technological and other factors identified under the
heading "Risk Factors" included in item 1A of Integra's Annual
Report on Form 10-K for the year ended December 31, 2016 and
information contained in subsequent filings with the Securities and
Exchange Commission could affect actual results. These
forward-looking statements are made only as the date thereof, and
the Company undertakes no obligation to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise.
Investor Relations: Michael BeaulieuDirector,
Investor Relations (609)
750-2827michael.beaulieu@integralife.com
Media Contact: Laurene Isip Senior Director,
Global Corporate Communications(609) 750
7984laurene.isip@integralife.com
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Feb 2024 to Mar 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Mar 2023 to Mar 2024